Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Scott Gottlieb
| The first 150 words of the full text of this article appear below. |
Scientists have identified the key structures of the anthrax bacterium that could lead to antitoxins and other treatments for the infection.
The research, some of it begun as long as five years ago, is fortuitously bearing fruit just as the disease is the focus of a biological terrorism scare in the United States. Any medicines arising from the work, however, will not appear for a year or two at the earliest, experts have said.
The National Institutes and the United States army are among the organisations starting to search for drugs based on the new studies, which will appear in the journal Nature this month but were released on the journal's website on 23 October (www.nature.com).
The anthrax toxin is composed of several distinct molecules. Before the
toxin enters a cell, its parts
"oedema" factor, "lethal" factor, and seven copies of "protective" factor
bind together as a
unit. They
What can you learn from this BMJ paper? Read Leanne Tite's Paper+